Osimertinib CAS 1421373-65-0

Khoom Piav Qhia

Cov Khoom Npe: AZD-9291; Osimertinib CAS TSIS: 1421373-65-0

Txhais:

2-Propenamide, N- [2 - [[2- (dimethylamino) ethyl] methylamino] -4-methoxy-5 - [[4- (1-methyl-1H-indol-3-yl) -2-pyrimidinyl] amino ] phenyl] -;

Osimertinib;

N- (2 - {[2- (Dimethylamino) ethyl] (methyl) amino} -4-methoxy-5 - {[4- (1-methyl-1H-indol-3-yl) -2-pyrimidinyl] amino} phenyl) acrylamide;

UNII-3C 06 JJ0Z 2 O;

Mereletinib;

AZD-9291;

Tshuaj& Lub cev nqaij daim tawv

Cov tsos: daj khoom.

Ntsuas: ≥ 99. 5%

Ntom: 1. 2 g / cm 3

Osimertinib (yav tas los hu ua mereletinib lossis AZD 9291; kev lag luam npe Tagrisso) yog tus kabmob thiav peb ntawm cov kabmob muaj kabmob (EGFR) tyrosine kinase inhibitor (TKI) tshuaj tsim los ntawm AstraZeneca kws tshuaj - rau kev hloov pauv ntawm EGFR qog nqaij hlav.

Osimertinib (AZD-9291) yog qhov hloov tsis tau thiab hloov kev xaiv EGFR inhibitor nrog IC 50 s ntawm 12 thiab 1 nM tiv thaiv EGFRL 858 R thiab EGFRL 858 R / T 790 M, ua raws.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: osimertinib cas 1421373-65-0, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: AZD-9291 Mesylate; Osimertinib Mesylate CAS 1421373-66-1
• Tom ntej: 5-Bromo-2-pyridinecarbonitrile CAS 97483-77-7